Ethics approval
We have complied with all relevant ethical regulations in analyzing these data. For COV-2069 the central or local institutional review board or ethics committee at each study center oversaw trial conduct and documentation. The central IRB was WCG-IRB For COVE a central institutional review board, Advarra, approved the protocol and the consent forms. Informed consent was obtained for all subjects in the COV-2069 and COVE trials. The ClinicalTrials.gov numbers were NCT04470472 and NCT04452318 for COVE and COV-2069, respectively.